Anthony N. Amato - 11 Sep 2024 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: BSGM
Reported as of: 11 Sep 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Sep 2024, 16:05:21 UTC
Prior SEC filing: 05 Jul 2024
Next SEC filing: 29 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Anthony Amato

Key filing fact

Anthony N. Amato filed Form 4 for BioSig Technologies, Inc. (BSGM) on 13 Sep 2024.

Key facts

This page summarizes Anthony N. Amato's Form 4 filing for BioSig Technologies, Inc. (BSGM).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Sep 2024, 16:05.

Change

Previous filing in this sequence was filed on 05 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSGM transaction

Common Stock

Award

Transaction value: $0
Shares: +275,000
Change %: +49%
Price: $0.000000
Shares after: 833,202
Date: 11 Sep 2024
Ownership: Direct
Footnotes: F1

BSGM transaction

Common Stock

Award

Transaction value: $0
Shares: +1,275,000
Change %: +153%
Price: $0.000000
Shares after: 2,108,202
Date: 11 Sep 2024
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSGM transaction Derivative

Option (right to buy)

Award

Transaction value
Shares: +2,400,000
Change %
Price
Shares after: 2,400,000
Date: 11 Sep 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,400,000
Exercise price: $0.4479
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares of restricted stock were granted and fully vested as of September 11, 2024 (the "Date of Grant"), based on a closing price of $0.4479 per share on such date.

Footnote F2

The shares of restricted stock vest biannually over three years in equal installments with vesting commencing on the Date of Grant, based on the closing price of $.04479 per share on such date.

Footnote F3

The option to purchase shares of the Issuers common stock (the "Option") has an exercise price of $0.4479 per share. 1,200,000 of the Option vested and became exercisable on the Date of Grant and the remaining 1,200,000 unvested Option will vest bi-annually over the term of 3 years commencing on the Date of Grant, subject to continued service with the Company through each relevant vesting date.